NMR imaging of changes in vascular morphology due to tumor angiogenesis

Tumor‐sprouted vessels are greater in both number and diameter in comparison to their healthy counterparts. A novel technique based on magnetic susceptibility contrast mechanisms that are sensitive to varying sizes of blood vessels is presented to measure differences between the relaxation rates (1/T2 and 1/T  2* ) in a rat glioma model and normal cerebral cortex. ΔR2 and ΔR2*, the differences between relaxation rates precontrast and postcontrast agent injection, were measured for an intravascular equilibrium contrast agent (MION) at various echo times. Since ΔR2*/ΔR2 increases as vessel size increases, this ratio can be used as a measure of the average vessel size within an ROI or a voxel. The stability and longevity of the contrast agent within the vasculature were verified (n = 2 trials), and the ratio of ΔR2*/ΔR2 between the tumor and normal cortex was measured to be 1.9 ± 0.2 (n = 4, echo time = 20 ms, and susceptibility difference (Δχ) ≈︁ 10−6). This ratio compared favorably to a predicted ratio determined using histologically determined vessel sizes and theoretical Monte Carlo modeling results (1.9 ± 0.1). Maps of the ratio of ΔR2*/ΔR2 were also made on a pixel‐by‐pixel basis. These techniques support the hypothesis that susceptibility contrast MRI can provide useful quantitative metrics of in vivo tumor vascular morphology.

[1]  J. Papadimitriou,et al.  Structural and functional characteristics of the microcirculation in neoplasms , 1975, The Journal of pathology.

[2]  R K Jain,et al.  Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.

[3]  J. Posner,et al.  Opening the blood–brain and blood–tumor barriers in experimental rat brain tumors: The effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow , 1986, Annals of neurology.

[4]  P Okunieff,et al.  Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. , 1994, International journal of radiation oncology, biology, physics.

[5]  M. Prammer,et al.  A multiple-frequency coil with a highly uniform B1 field , 1989 .

[6]  B. Rosen,et al.  Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects , 1988, Magnetic resonance in medicine.

[7]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[8]  S. Green,et al.  Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.

[9]  B R Rosen,et al.  Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.

[10]  J. Gore,et al.  Intravascular susceptibility contrast mechanisms in tissues , 1994, Magnetic resonance in medicine.

[11]  J. Folkman What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[12]  R Weissleder,et al.  Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.

[13]  P. Lantos,et al.  The vasculature of experimental brain tumours Part 1. A sequential light and electron microscope study of angiogenesis , 1981, Journal of the Neurological Sciences.

[14]  B. Rosen,et al.  Susceptibility contrast imaging of cerebral blood volume: Human experience , 1991, Magnetic resonance in medicine.

[15]  J F Gross,et al.  Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. , 1989, International journal of radiation oncology, biology, physics.

[16]  Harold E. Dvorak,et al.  Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels , 1991, The Journal of experimental medicine.

[17]  M. Ter-pogossian,et al.  Radioactive oxygen-15 in the study of cerebral blood flow, blood volume, and oxygen metabolism. , 1985, Seminars in nuclear medicine.

[18]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[19]  D M Shames,et al.  Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. , 1996, Radiology.

[20]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[21]  Ravi S. Menon,et al.  Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. , 1993, Biophysical journal.

[22]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[23]  Marcus E. Raichle,et al.  Measurement of regional cerebral blood volume by emission tomography , 1978, Annals of neurology.

[24]  B. Rosen,et al.  MR Contrast Due to Microscopically Heterogeneous Magnetic Susceptibility: Numerical Simulations and Applications to Cerebral Physiology , 1991, Magnetic resonance in medicine.

[25]  J. Folkman,et al.  Tumor Behavior in Isolated Perfused Organs: In Vitro Growth and Metastases of Biopsy Material in Rabbit Thyroid and Canine Intestinal Segment , 1966, Annals of surgery.

[26]  M. Neeman,et al.  Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Ullrich,et al.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.

[28]  J. Folkman Angiogenesis and breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.